NCT02541565
- Conditions
- Composite Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Composite Lymphoma
Explore clinical trials studying Composite Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Composite Lymphoma trial results
Active, Not Recruiting
ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
NCT05025800
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +31 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States